secwatch.observer — SEC 8-K summary
======================================

Issuer:     TITAN PHARMACEUTICALS INC (—)
CIK:        0000910267
Form:       8-K
Filed at:   2024-10-24T23:59:59+00:00
Accession:  0001829126-24-006949
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Titan Pharmaceuticals CEO Dato' Seow Gim Shen resigns; search for replacement launched
--------------------------------------------------------------------------------

- CEO and Chairman Dato' Seow Gim Shen resigned on October 24, 2024 for personal reasons, no disagreement with board or management.
- Company has commenced a search for a new CEO; resignation not expected to impact pending business combination with KE Sdn. Bhd.
- Resignation effective immediately; Brynner Chiam signed the 8-K as a Board member.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/910267/000182912624006949/0001829126-24-006949-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/910267/000182912624006949/titanpharma_8k.htm
  HTML page:      https://secwatch.observer/filing/0001829126-24-006949

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer